Friess Associates’s Electromed ELMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$488K Sell
50,614
-15,600
-24% -$184K 0.81% 32
2022
Q1
$824K Buy
66,214
+2,864
+5% +$35.9K 0.44% 70
2021
Q4
$824K Buy
+63,350
New +$743K 0.32% 74
2020
Q2
Sell
-142,000
Closed -$1.6M 110
2020
Q1
$1.6M Buy
+142,000
New +$1.45M 0.16% 83

Other funds holding ELMD

Friess Associates's ELMD Position: Q2 2022 in Review

Friess Associates reduced its Electromed (ELMD) stake by 24% in Q2 2022, selling an estimated $184K and leaving 50,614 shares worth $488K. The position accounts for 0.81% of the portfolio, ranked #32.

Friess Associates first reported a position in ELMD in Q1 2020 and has held it in 4 quarters since. The position peaked at $1.6M in Q1 2020. 38 funds tracked by Wall St. Rank hold ELMD as of Q2 2022.

  • Friess Associates held 50,614 shares of Electromed worth $488K as of Q2 2022.
  • Friess Associates sold 15,600 Electromed shares in Q2 2022, an estimated $184K.
  • Electromed made up 0.81% of Friess Associates's portfolio in Q2 2022, its #32 holding.
  • Friess Associates first reported a position in Electromed in Q1 2020 and has held it in 4 quarters since.
  • Friess Associates's Electromed position peaked at $1.6M in Q1 2020.
  • 38 funds tracked by Wall St. Rank held Electromed as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.